ALXO Valuation

ALX Oncology Holdings Inc (ALXO) has a current Price-to-Book (P/B) ratio of 1.77. Compared to its 3-year average P/B ratio of 1.52 , the current P/B ratio is approximately 16.55% higher. Relative to its 5-year average P/B ratio of 2.54, the current P/B ratio is about -30.44% higher. ALX Oncology Holdings Inc (ALXO) has a Forward Free Cash Flow (FCF) yield of approximately -122.25%. Compared to its 3-year average FCF yield of -120.58%, the current FCF yield is approximately 1.38% lower. Relative to its 5-year average FCF yield of -75.67% , the current FCF yield is about 61.55% lower.